Investments in Research
Georgia CORE has developed and nurtured collaboration with other organizations working to fight cancer which has enabled us to further our dollars and increase the impact on advancements in cancer research.
Breast Cancer Research Partnership Award
In 2019, Georgia CORE, with equal contributions from It’s The Journey and A Cure In Our Lifetime Atlanta awarded a $100,000 grant to Veena Rao, PhD Morehouse School of Medicine for Triple Negative Breast Cancer Research. In 2018, grants totaling $150,000 were given with It's the Journey to (pictured from left to right) Cheryl Gomillion, PhD of the University of Georgia Research Foundation; Adam Marcus, PhD of Emory University; and Dr. Rao. The partnership award was first granted with It's the Journey in 2017, when Susan Thomas, PhD, Assistant Professor, Institute of Bioengineering and Biosciences, Department of Mechanical Engineering, Georgia Institute of Technology; Mandi Murph, PhD, Associate Professor, Department of Pharmaceutical and Biomedical Sciences, University of Georgia; and Ritu Aneja, PhD, Adjunct Professor, Center for Inflammation, Immunity and Infection, Department of Biology, Georgia State University were granted $50,000 each. An additional $25,000 was awarded to Dora Il’yasova, Associate Professor of Epidemiology and Biostatistics, School of Public Health, Georgia State University.
Georgia Cancer Research Fund
Money contributed by Georgia CORE for the Breast Cancer Research Partnership Award comes from the Georgia Cancer Research Fund, administered by Georgia CORE but funded by Georgia Taxpayers. Find out how you can contribute here.
Patient-Centered Outcomes Research
in 2015, Georgia CORE received a multi-tiered award from the Patient-Centered Outcomes Research Institute (PCORI) to support “Patient-Centered Cancer Survivorship Care: Improving Quality of Care and Quality of Life for Survivors in Georgia.” The award from PCORI has enabled Georgia CORE to engage cancer survivors, healthcare providers and many other stakeholders in the process of developing research to address the needs of vulnerable cancer survivors in Georgia. Now Georgia CORE is in the process of securing funding for the next stage of the research,
Gynecologic Oncology Group Consortium
The Georgia CORE Gynecologic Oncology Group Consortium was created in 2007 as a unique, collaborative model to provide access to National Cancer Institute-sponsored gynecologic clinical trials by affiliated gynecologic oncologists throughout the state. Since its inception, the Consortium has enrolled more than 225 patients on clinical trials, roughly one-quarter of whom are racial/ethnic minorities. This Consortium became a full member of the Gynecologic Oncology Group (GOG) in 2009 after two years of provisional membership. The Georgia CORE GOG Consortium has demonstrated the effectiveness of this innovative approach in several critical areas: growth of academic and community-based affiliates; volume of enrollment on GOG studies; enrollment of minority and rural patients; quality of data as determined by monitoring and auditing; participation in high priority and Phase I studies; and leadership on national GOG committees. In 2013, nine organizations were affiliated with the Georgia CORE GOG Consortium. During that year, the Consortium acquired nearly four times the required number of membership points.
In 2014, NCI's GOG transitioned into NRG Oncology; Georgia CORE became a main voting member of NRG Oncology, and then a partner in Georgia NCI Community Oncology Research Program (NCORP).
Georgia CORE staff and board members have also contributed to a number of research publications, some of which are listed here, including a 2018 article in the The Journal of Clinical Oncology which features the first ten years of Georgia CORE's research network and our focus on clinical trials.